<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Several large cohorts of patients treated with <z:chebi fb="0" ids="22333">alkylating agents</z:chebi> served as a means to review the clinical and pathologic features of 55 cases of myelopathic disorders that resulted </plain></SENT>
<SENT sid="1" pm="."><plain>The incidence was 1.8% overall and consisted of five patients (9.9%) who developed <z:hpo ids='HP_0005528'>bone marrow hypoplasia</z:hpo> or <z:mpath ids='MPATH_58'>aplasia</z:mpath>, 15 (27.2%) who developed a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, and 35 cases of <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (62.9%) </plain></SENT>
<SENT sid="2" pm="."><plain>The median time to recognition of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e> was 14 months, following cessation of chemotherapy </plain></SENT>
<SENT sid="3" pm="."><plain>The distribution of the treatment-related <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cases was different than "de novo" <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with a high percentage of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e>, and with the <z:e sem="disease" ids="C1336735" disease_type="Neoplastic Process" abbrv="">treatment related AMLs</z:e>, there were a higher percentage of patients with <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">FAB M6</z:e> (<z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukemia</z:e>), and no cases of <z:e sem="disease" ids="C0023487" disease_type="Neoplastic Process" abbrv="APML">FAB M3</z:e> (hypergranular promyelocytic) </plain></SENT>
<SENT sid="4" pm="."><plain>The median survival of <z:hpo ids='HP_0000001'>all</z:hpo> patients was very brief </plain></SENT>
</text></document>